Perry is a current Kenvue director and seasoned consumer products and brand strategist with more than 30 years of experience.

Kenvue appoints Kirk Perry as interim CEO after Thibaut Mongon's exit and launches strategic review to simplify operations.

Kenvue said Monday that its board was taking steps to realize shareholder value and allow the company to “reach its full ...

American consumer health company Kenvue's Board of Directors announced new actions to unlock shareholder value and an interim ...

Kenvue’s board of directors are considering ‘a broad range of potential alternatives’ and are hunting for a permanent ...

Kenvue chief executive officer, Thibaut Mongon, has stepped down from the role and the company's board amid an ongoing ...

Band-Aid and Tylenol maker Kenvue has fired its CEO Thibaut Mongon, the consumer health company said on Monday, laying what ...

With activist investor Starboard Value holding a seat on Kenvue’s board of directors, the consumer healthcare company is ...

Kenvue, the Johnson & Johnson spinoff that owns brands such as Tylenol and Benadryl, announced Monday that Chief Executive ...

Current Kenvue Director, Kirk Perry, is named Interim CEO, effective immediately. Kenvue Board of Directors appointed a new Interim CEO and is advancing an ongoing comprehensive review of strategic ...

Kenvue says that CEO Thibaut Mongon is departing as the maker of Listerine and Band-Aid brands continues with a strategic ...

Kenvue, formerly part of Johnson & Johnson, announces CEO Thibaut Mongon's departure as it undergoes a strategic review.